237 related articles for article (PubMed ID: 6167076)
1. [Serum alpha-1-fetoprotein and serum lactic dehydrogenase isoenzymes in liver tumours (author's transl)].
Polterauer P; Rauhs R; Puxkandl H
Wien Klin Wochenschr; 1981 Apr; 93(7):227-30. PubMed ID: 6167076
[TBL] [Abstract][Full Text] [Related]
2. [Serum-alpha 1-fetoprotein and serumferritin in liver tumours (author's transl)].
Polterauer P; Linkesch W
Wien Klin Wochenschr; 1982 Feb; 94(4):105-8. PubMed ID: 6177107
[TBL] [Abstract][Full Text] [Related]
3. [Serum concentrations of tissue polypeptide antigen and alpha 1-fetoprotein in patients with primary liver cancer, liver metastasis and liver cirrhosis].
Polterauer P; Legenstein E; Müller M
Wien Klin Wochenschr; 1985 Apr; 97(9):417-20. PubMed ID: 2408389
[TBL] [Abstract][Full Text] [Related]
4. The characteristics of hepatocellular carcinoma with a high level of serum lactic dehydrogenase: a case report.
Fujiwara Y; Takenaka K; Kajiyama K; Maeda T; Gion T; Shirabe K; Shimada M; Sugimachi K
Hepatogastroenterology; 1997; 44(15):820-3. PubMed ID: 9222698
[TBL] [Abstract][Full Text] [Related]
5. [Serum concentrations of alpha-1-fetoprotein suggestive of, or pathognomonic for hepatoma (author's transl)].
Polterauer P; Horak W; Legenstein E; Müller M
Wien Klin Wochenschr; 1979 Mar; 91(6):201-4. PubMed ID: 85372
[TBL] [Abstract][Full Text] [Related]
6. [Serum lactic dehydrogenase isoenzymes in metastatic and primary liver carcinoma (author's transl)].
Kaito I; Sato S; Ishii T
Leber Magen Darm; 1976 Dec; 6(6):335-9. PubMed ID: 190500
[TBL] [Abstract][Full Text] [Related]
7. [alpha 1-fetoprotein and Tennessee antigen in hepatocellular carcinomas and in metastatic liver cancer (author's transl)].
Polterauer P; Müller M
Wien Klin Wochenschr; 1982 Feb; 94(4):102-5. PubMed ID: 6177106
[TBL] [Abstract][Full Text] [Related]
8. [Alkaline phosphatase isoenzymes and alpha-1-fetoprotein in hepatic neoplasms].
Di Blasi S; Cuffaro M; Rizzo S; Belvedere M; Genova G
Minerva Med; 1980 Apr; 71(14):1041-6. PubMed ID: 6154909
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of type III procollagen peptide in sera of patients with liver cancer].
Yamauchi M; Nakayama H; Fukuzawa K; Nakajima H; Takahara M; Nakahara M; Kawase H; Watanabe Y; Kimura K; Kitahara T
Gan No Rinsho; 1984 Jun; 30(7):785-90. PubMed ID: 6086978
[TBL] [Abstract][Full Text] [Related]
10. Aldolase A isoenzyme levels in serum and tissues of patients with liver diseases.
Asaka M; Nagase K; Miyazaki T; Alpert E
Gastroenterology; 1983 Jan; 84(1):155-60. PubMed ID: 6183164
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
12. [Value of the serum measurement of alpha-L-fucosidase in the diagnosis of hepatocarcinoma].
López Vivancos J; Segura RM; Oliva G; Vives L; Pascual C; Vilaseca J
Med Clin (Barc); 1989 Sep; 93(7):241-3. PubMed ID: 2478845
[TBL] [Abstract][Full Text] [Related]
13. [Comparative study of the plasma levels of alpha-1 fetoprotein and carcinoembryonic antigen in chronic liver diseases and malignant neoplasias (author's transl)].
Del Vecchio-Blanco C; Caporaso N; Balzano A; Grande R
Quad Sclavo Diagn; 1977 Sep; 13(3):288-97. PubMed ID: 77537
[TBL] [Abstract][Full Text] [Related]
14. The measurement of total lactic dehydrogenase and its isoenzymes in solid tumours.
Canal P; Bugat R; Soula G; Combes PF
Biomedicine; 1980 Nov; 33(7):222-6. PubMed ID: 7225499
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of serum "hepatoma-specific" gamma-glutamyl transferase and alkaline phosphatase].
Xu KC
Zhonghua Zhong Liu Za Zhi; 1985 Jul; 7(4):247-9. PubMed ID: 2417791
[TBL] [Abstract][Full Text] [Related]
16. Utility of ascitic fluid analysis in patients with malignancy-related ascites.
Salerno F; Restelli B; Incerti P; Annoni G; Capozza L; Badalamenti S; Lampertico P; Mojana E; Moser P; Tommasini M
Scand J Gastroenterol; 1990 Mar; 25(3):251-6. PubMed ID: 1690913
[TBL] [Abstract][Full Text] [Related]
17. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
18. [Serum arginase activity in patients with liver cirrhosis and hepatocellular carcinoma].
Chrzanowska A; Mielczarek-Puta M; Skwarek A; Krawczyk M; Barańczyk-Kuźma A
Wiad Lek; 2007; 60(5-6):215-8. PubMed ID: 17966882
[TBL] [Abstract][Full Text] [Related]
19. Preliminary observation on human saliva alpha-fetoprotein in patients with hepatocellular carcinoma.
You XY; Jiang J; Yin FZ
Chin Med J (Engl); 1993 Mar; 106(3):179-82. PubMed ID: 7686840
[TBL] [Abstract][Full Text] [Related]
20. An immunohistochemical survey of amylase isoenzymes in cholangiocarcinoma and hepatocellular carcinoma.
Terada T; Nakanuma Y
Arch Pathol Lab Med; 1993 Feb; 117(2):160-2. PubMed ID: 8381270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
